Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind”

December 2, 2014 – 4:31 am | Edit Post

Biotech companies rarely go bankrupt. Sitting where I sit, that bit of conventional wisdom comes around every so often, although it doesn’t generate quite the same buzz as Halley’s Comet…
[[Click headline to continue reading.]]

More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind”

December 2, 2014 – 4:31 am | Edit Post

Biotech companies rarely go bankrupt. Sitting where I sit, that bit of conventional wisdom comes around every so often, although it doesn’t generate quite the same buzz as Halley’s Comet…
[[Click headline to continue reading.]]

More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind”

December 2, 2014 – 4:31 am | Edit Post

Biotech companies rarely go bankrupt. Sitting where I sit, that bit of conventional wisdom comes around every so often, although it doesn’t generate quite the same buzz as Halley’s Comet…
[[Click headline to continue reading.]]

Prescription Drug Pricing: The Fine Line Between Value and Greed

December 2, 2014 – 1:00 am | Edit Post

Value. It’s one of the most frequently used buzzwords on both Wall Street and in healthcare. Virtually every press release from a publicly traded company assures us that its latest…
[[Click headline to continue reading.]]

Prescription Drug Pricing: The Fine Line Between Value and Greed

December 2, 2014 – 1:00 am | Edit Post

Value. It’s one of the most frequently used buzzwords on both Wall Street and in healthcare. Virtually every press release from a publicly traded company assures us that its latest…
[[Click headline to continue reading.]]

Prescription Drug Pricing: The Fine Line Between Value and Greed

December 2, 2014 – 1:00 am | Edit Post

Value. It’s one of the most frequently used buzzwords on both Wall Street and in healthcare. Virtually every press release from a publicly traded company assures us that its latest…
[[Click headline to continue reading.]]

San Diego biotechs dominate innovation list

December 1, 2014 – 7:05 pm | Edit Post

San Diego’s fame for biotech innovation is boosted by a major life science magazine.

San Diego biotechs dominate innovation list

December 1, 2014 – 7:05 pm | Edit Post

San Diego’s fame for biotech innovation is boosted by a major life science magazine.

OncoSec Medical Inc. Collaborates With PerkinElmer, Inc. And University of California, Los Angeles (UCLA) To Evaluate Patient-Selection Biomarker In Immunotherapy

December 1, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced a collaboration with PerkinElmer, Inc. and the University of California, Los Angeles (UCLA) to help researchers develop biomarker tests to evaluate a patients immune response to cancer. This research supports the ongoing shift in oncology toward therapeutic…

MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Completes Enrollment In Phase 2 Study Of Pracinostat In Front Line Acute Myeloid Leukemia

December 1, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Dec. 2, 2014 /PRNewswire/ –MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a Phase II clinical study of its investigational drug candidate Pracinostat in combination with azacitidine…